Related Experiment Video
Updated: Mar 9, 2026
08:20
In Vitro Model of Human Cutaneous Hypertrophic Scarring using Macromolecular Crowding
Published on: May 1, 2020
7.2K
Non-Coding RNAs: The New Insight on Hypertrophic Scar
Ling Chen1, Jingyun Li1, Qian Li1
1Department of Plastic and Cosmetic Surgery, Maternal and Child Health Medical Institute, Obstetrics and Gynecology Hospital Affiliated to Nanjing Medical University, Nanjing 210004, China.
Journal of Cellular Biochemistry
|January 10, 2017
Summary
Non-coding RNAs (ncRNAs) are crucial in hypertrophic scarring (HS) development. Targeting these molecules offers a promising therapeutic strategy for effective scar treatment.
Area of Science:
- Biochemistry
- Dermatology
- Molecular Biology
Background:
- Hypertrophic scarring (HS) results from abnormal wound healing, marked by excessive extracellular matrix deposition and fibroblast proliferation.
- Non-coding RNAs (ncRNAs), including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), are increasingly recognized for their significant roles in HS pathogenesis.
Purpose of the Study:
- To investigate the role of ncRNAs in the formation of hypertrophic scars.
- To explore the potential of ncRNA-based therapies for treating hypertrophic scarring.
Main Methods:
- Literature review of studies on ncRNAs and hypertrophic scarring.
- Analysis of the molecular mechanisms underlying ncRNA involvement in fibroblast behavior and extracellular matrix production.
Main Results:
- Evidence suggests that specific miRNAs and lncRNAs are dysregulated in hypertrophic scars.
- These ncRNAs influence key cellular processes implicated in scar formation, such as fibroblast proliferation and collagen synthesis.
Conclusions:
- ncRNAs are critical regulators in the development of hypertrophic scars.
- Targeting ncRNAs presents a novel and promising therapeutic avenue for managing and treating hypertrophic scarring.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
10.1K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
01:13Formation of Muscle Fibers from Myoblasts
6.3K
De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
6.3K
01:19Clinical Applications of Epidermal Stem Cells
3.4K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.4K